(Incorporated in the Cayman Islands)

We are a newly organized blank check company – also known as a special purpose acquisition company (SPAC). Although we currently intend to focus on target businesses in traditional sectors that can be transformed through the application of automation and artificial intelligence, we may pursue an acquisition opportunity in any business, industry, sector or geographical location.

Justin Di Rezze, 38, has served as our CEO and as a director of our company since our incorporation on Sept. 29, 2025. He is the managing member of our sponsor, Praetorian Sponsor LLC. Dr. Di Rezze is the founder and former CEO of Theoria Medical, a national physician services and healthcare technology organization operating across skilled nursing facilities, assisted living centers, and telehealth networks that is one of the largest providers of post-acute care in the United States.

Peter Ondishin, 38, has served as the CFO since November 2025 and he is expected to serve as a director of our company. He has also served as chief financial officer of Inflection Point Acquisition Corp. III, a special purpose acquisition company, since November 2024. Mr. Ondishin served as CFO of Inflection Point Acquisition Corp. II, a special purpose acquisition company, from March 2023 to March 2025, and he was previously an employee of Inflection Point Acquisition Corp., a special purpose acquisition company. Mr. Ondishin has been the chief financial officer of The Venture Collective since June 2023. He was previously the chief financial officer of Kingstown Capital Management from August 2020 to December 2023 and the controller of Kingstown from April 2019 to August 2020. Mr. Ondishin was the assistant controller for Atlantic Investment Management from January 2016 to March 2019. Before that, Mr. Ondishin worked as an accountant for Fir Tree Partners from January 2014 to January 2016. Mr. Ondishin began his career in assurance at PwC. He is also a CPA.

(Note: Praetorian Acquisition Corp. filed its S-1 for its SPAC IPO on Nov. 14, 2025, and disclosed the terms: 22 million units at $10.00 each to raise $220 million. Each unit consists of one share of stock and one-third of one redeemable warrant.)